Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 5 Deoxy D ribofuranose Derivative. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111100172B reveals a mild Lewis acid catalyzed route for high-purity capecitabine intermediates, offering significant cost and supply chain advantages.
Novel catalytic route for Capecitabine using 5-deoxy-D-ribofuranose derivatives, offering high yield and mild conditions for API manufacturing.